2000
$76M
from 3 investors over 3 rounds
Basilea Pharmaceutica raised $76M on September 7, 2022
Investors: Athyrium Capital Management, LP
Basilea Pharmaceutica raised $4.3M on August 16, 2021
Investors: Biomedical Advanced Research and Development Authority (BARDA)
Basilea Pharmaceutica raised $2.7M on May 19, 2021
Investors: CARB-X